May 02, 2023 1 min read

Want to know how we help? 

After years in the field, an international NGO supporting clinics in Tanzania, Uganda, Nigeria, and Haiti, had found that obstetric hemorrhage was one of the biggest preventable causes of maternal mortality. They were then looking to purchase the Non-Pneumatic Anti Shock Garment (NASG), a low-cost, evidence-based, first-aid device used to stabilize women experiencing obstetric hemorrhage. 

After a thorough search, they found Maternova offered the best path to acquiring the NASG. During discussions with our team, Maternova offered tailored advice on how to best pair the NASG with other low-cost, life-saving devices designed to prevent obstetric hemorrhage, like the CRADLE Vitals Monitor and the Obstetric Ballon. Based on the recommendations made by Maternova’s Chief Medical Officer, Dr. Luna Mehrain, they ordered the three products and incorporated them into their health programs and training sessions. To ease the introduction of the products into the work of their medical teams in Tanzania, Uganda, and Nigeria (50 professionals in total), Dr. Luna Mehrain offered a custom, live training on best practices for the three products.

This story is one of many where Maternova demonstrated a high level of medical expertise and efficiency to support its NGO clients. Paying close attention to medical innovations in this field, Maternova can offer tailored medical advice and products to your teams, supporting you in promoting maternal and neonatal health around the globe.

Leave a comment

Comments will be approved before showing up.


Also in The Maternova Blog

MUAC could help screen for Low Birth Weight and More in Pregnant Women
MUAC could help screen for Low Birth Weight and More in Pregnant Women

September 25, 2023 2 min read

Read More
Postpartum Depression Revisited: A Look at the New Postpartum Depression Pill
Postpartum Depression Revisited: A Look at the New Postpartum Depression Pill

September 21, 2023 2 min read

Postpartum depression (PPD) affects 1 in 7 new mothers and can lead to severe risks for both mother and baby if untreated. In 2019, the FDA approved Zulresso, a costly hospital-administered drug. Recently, the FDA approved Zurzuvae, the first oral PPD treatment, offering a more accessible and home-based option.
Read More
Then and Now: Cervical Cancer can be Eliminated. The Bouquet Speculum may be the Solution.
Then and Now: Cervical Cancer can be Eliminated. The Bouquet Speculum may be the Solution.

September 01, 2023 3 min read

Read More